They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the ...

Merck (MRK) is a leading global healthcare company recognized for its groundbreaking pharmaceutical products and vaccines.

Merck reported Q4 sales of $15.62 billion, surpassing estimates, with EPS at $1.72. Goldman Sachs remains bullish despite a ...

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.

Gardasil sales have slumped there for a few quarters ... For 2025 Merck expects adjusted earnings to range between $8.88 and $9.03 per share on $64.1 billion to $65.6 billion in sales.

It is a cancer that is preventable and highly treatable if people have access to the right kind of medical professionals and ...

An experimental therapeutic human papillomavirus (HPV) vaccine showed promise in inducing regression of precancerous cervical lesions as well as viral clearance in patients with cervical ...

Kennedy has in particular focused on Gardasil, the HPV vaccine. A lawyer by trade, he has helped facilitate hundreds of potential lawsuits aimed at pharmaceutical company Merck, which manufactures ...

However, a significant tool in the fight against this preventable disease is the Human Papillomavirus (HPV) vaccine. This vaccine, which is both safe and effective, offers a clear path to reducing ...

Japan approved the use of the HPV vaccine in 2009. In April 2013, girls between the sixth grade of elementary school and the first year of high school, aged between 11 to 16, became eligible for ...